Pharmaceuticals & Healthcare Products
186 posts · page 3 of 8
Pharma innovation clusters and their potential for scaling research
Pharma clusters boost collaboration, driving research breakthroughs.
Public-private partnerships in pharma manufacturing and development
Collaborative efforts boost innovation in pharma development.
The role of generics versus branded generics in the Indian healthcare system
Generics offer affordability, but branded generics build trust.
Investment in local API parks and their expected outcomes
Local API parks promise economic growth and community benefits.
Ethical sourcing and supply chain transparency in pharma ingredients
Ensuring transparency in pharma sourcing builds trust and safety.
AI and machine learning applications in Indian drug discovery
AI is transforming drug discovery in India, boosting innovation.
Telemedicine and pharmaceutical delivery regulation post COVID
Post-COVID, telemedicine regulations are rapidly evolving.
How India is preparing for future pandemics with vaccine capacity
India boosts vaccine production to combat future pandemics.
Counterfeit and substandard drugs and policy efforts to address them
Combatting counterfeit drugs requires urgent global policy reform.
Quality failures and recalls in Indian pharma and lessons learned
Indian pharma faces critical quality issues and recalls.
Export destination diversification and reducing reliance on few major markets
Exploring new markets can boost export stability and growth.
How Indian pharma is leveraging global partnerships and licensing deals
Indian pharma thrives through global partnerships and licensing.
The role of biosafety and biosecurity regulations in drug manufacturing
Biosafety regulations ensure safer drug production practices.
Pharma responses to inflation, input cost pressures and currency volatility
Pharma adapts strategies to tackle rising costs and volatility.
Efforts around generating local clinical data in India
Building local clinical data is vital for India's healthcare future.
Strategies for managing excipient and packaging cost increases
Navigate rising excipient and packaging costs with smart strategies.
Patient safety and pharmacovigilance developments in the Indian market
India enhances patient safety through innovative pharmacovigilance.
Impacts of trade agreements on pharma inputs and finished drugs
Trade agreements shape the landscape of pharmaceutical access.
The role of small and medium enterprises in India’s pharma exports
SMEs drive innovation and growth in India's pharma exports.
Trends in vaccine development and local manufacturing capacity
Local vaccine production is reshaping global health strategies.
Demand shifts in tier-2 and tier-3 cities shaping pharma strategies
Pharma strategies evolve as demand rises in smaller cities.
Reforms allowing conditional approvals for breakthrough therapies
New reforms speed up access to innovative therapies.
India’s strategy on biosimilars and pricing comparisons with biologics
India is redefining biosimilars, balancing affordability and quality.
Impact of digital marketing regulations on pharma brand awareness
New regulations reshape how pharma brands connect online.